社区获得性肺炎(CAP)是指在医院外罹患的感染性肺实质炎症,包括具有明确潜伏期的病原体感染而入院后平均潜伏期内发病的肺炎。莫西沙星作为新一代福喹诺酮类药物,由于其可靠的疗效和安全性,近年来被应用于呼吸道感染,不仅快速缓解症状,疗程短,并且每日一次用药,用药方便,患者依从 Community acquired pneumonia (CAP) refers to infectious pulmonary parenchymal inflammation that occurs outside the hospital, including those with a clear latent period of infection of the pathogen and an average incubation period after admission. As a new generation of fluoroquinolones, moxifloxacin has been applied to respiratory infections in recent years because of its reliable curative effect and safety. It not only relieves symptoms quickly and has short course of treatment, but also takes daily medication, convenient medication and patient compliance